Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy.

Vivian RoseryStephan MikaKurt Werner SchmidHenning ReisMartin StuschkeJürgen TreckmannPeter MarkusBrigitte SchumacherDavid AlbersBastian MendeHarald LahnerMarcel WieswegMartin SchulerJens T SivekeStefan Kasper

Published in: Journal of cancer research and clinical oncology (2022)

Outcomes of patients with GEP-NEN G3 are still limited. A new prognostic score identifying those patients benefitting from current platinum/etoposide-based chemotherapy protocols may help as stratification factor in future trial design.

Keyphrases

high grade
end stage renal disease
newly diagnosed
ejection fraction
squamous cell carcinoma
chronic kidney disease
locally advanced
small cell lung cancer
clinical trial
palliative care
study protocol
patient reported outcomes
metabolic syndrome
adipose tissue
chemotherapy induced
advanced cancer